A Certified Reference Material of tauroursodeoxycholic acid
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Tauroursodeoxycholic Acid (CRM)

Item No. 44871

Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
2-[[(3α,5β,7β)-3,7-dihydroxy-24-oxocholan-24yl]amino]-ethanesulfonic acid
CAS Number
14605-22-2
Synonyms
  • 3α,7β-dihydroxy-5β-cholanoyl Taurine
  • TUDCA
  • UR-906
Molecular Formula
C26H45NO6S
Formula Weight
499.7
Formulation (Request formulation change)
A 1 mg/ml solution in methanol
SMILES
C[C@H](CCC(NCCS(O)(=O)=O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@@]21C
InChi Code
InChI=1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17+,18-,19-,20+,21+,22+,24+,25+,26-/m1/s1
InChi Key
BHTRKEVKTKCXOH-LBSADWJPSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $89

    Add
    Product Description

    Tauroursodeoxycholic acid (CRM) (Item No. 44871) is a certified reference material categorized as a conjugated bile acid.1,2 It is a taurine-conjugated form of the secondary bile acid ursodeoxycholic acid (Item No. 15121). Serum levels of tauroursodeoxycholic acid are increased in individuals with intrahepatic cholestasis of pregnancy (ICP).3 This product is intended for use in analytical research applications. This product is also available as a general research tool (Item Nos. 20277 | 9003379).

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Beuers, U. Effects of bile acids on hepatocellular signaling and secretion. Yale J. Biol. Med. 70(4), 341-346 (1997).

    2. Boatright, J.H., Nickerson, J.M., Moring, A.G., et al. Bile acids in treatment of ocular disease. J. Ocul. Biol. Dis. Infor. 2(3), 149-159 (2009).

    3. Yang, Z., Yao, M., Zhang, C., et al. Application of metabolomics in intrahepatic cholestasis of pregnancy: A systematic review. Eur. J. Med. Res. 27(1), 178 (2022).